Search Results

Genta obtains FDA fast track designation for gastric cancer drug.

Subjects: STOMACH cancer treatmentGENTA Inc. GENTA Inc. GENTA Inc. GNTA; UNITED States. Food & Drug Administration

• Source: PharmaWatch: Biotechnology. May2010, Vol. 9 Issue 5, p12-13. 2p.

Record details

Genta Reports on Tesetaxel Trial For Gastric Cancer.

Subjects: CLINICAL trials; STOMACH cancer treatment; CANCER patients

• Source: Biotech Business. Jul2012, Vol. 25 Issue 7, p1-3. 3p.

Record details

show case.

Subjects: HEMOPHILIA treatment; STOMACH cancer treatment; HEADACHE treatmentUNITED States. Food & Drug Administration ; BIOGEN Inc. (2003- ) BIOGEN Inc. (2003- ) BIOGEN Inc. (2003- ) BIIB; ELI Lilly & Co. ELI Lilly & Co. ELI Lilly & Co. LLY

• Source: Pharmacy Today. May2014, Vol. 20 Issue 5, p21-22. 2p.

Record details

Gambogic acid-loaded PEG–PCL nanoparticles act as an effective antitumor agent against gastric cancer.

• Authors : Zhang, Dinghu¹ (AUTHOR); Zou, Zhengyun² (AUTHOR); Ren, Wei² (AUTHOR)

Subjects: STOMACH cancer treatment; STOMACH cancer patients; ANTINEOPLASTIC agents

• Source: Pharmaceutical Development & Technology. Jan2018, Vol. 23 Issue 1, p33-40. 8p.

Record details

Angiogenesis in gastric cancer: hitting the target?

• Authors : Ilson, David H.¹

Subjects: STOMACH cancer treatment; THERAPEUTIC use of monoclonal antibodies; ADENOCARCINOMA

• Source: Lancet. 1/4/2014, Vol. 383 Issue 9911, p4-6. 3p. 1 Color Photograph.

Record details

The second British Stomach Cancer Group trial of adjuvant radiotherapy or chemotherapy in...

• Authors : Hallissey, Michael T; Dunn, Janet A

Subjects: STOMACH cancer treatment

• Source: Lancet. 5/28/1994, Vol. 343 Issue 8909, p1309. 4p. 4 Charts, 2 Graphs.

Record details

Aphton reports positive results for gastric cancer therapy.

Subjects: STOMACH cancer treatment; CANCER chemotherapy; CANCER immunotherapyAPHTON Corp. 102846003 APHTON Corp. APHTON Corp. 102846003 102846003 APHTON Corp. 102846003 APHT

• Source: PharmaWatch: Cancer. March 2004, Vol. 3 Issue 3, p7-7. 1p.

Record details

Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trial.

• Authors : Kohei Shitara¹ ; Ӧzgϋroǧlu, Mustafa²; Yung-Jue Bang³

Subjects: *RESEARCH; *STATISTICAL sampling; STOMACH cancer treatment

• Source: Lancet. 7/14/2018, Vol. 392 Issue 10142, p123-133. 11p. 1 Diagram, 2 Charts, 3 Graphs.

Record details

Are We Lacking Economic Evaluations in Gastric Cancer Treatment?

• Authors : Mahar, Alyson¹; El-Sedfy, Abraham; Brar, Savtaj²

Subjects: *COST effectiveness; *MEDICAL economics; *COST analysis

• Source: PharmacoEconomics. Feb2015, Vol. 33 Issue 2, p83-87. 5p. 1 Chart.

Record details

Preparation and in vitro investigation of antigastric cancer activities of carvacrol-loaded human serum albumin nanoparticles.

• Authors : Maryam, Keshavarzi¹; Shakeri, Shahryar¹ ; Kiani, Keyhaneh¹

Subjects: ANTINEOPLASTIC agents; STOMACH cancer treatment; CARVACROL

• Source: IET Nanobiotechnology (Wiley-Blackwell). 2015, Vol. 9 Issue 5, p294-299. 6p. 3 Black and White Photographs, 2 Charts, 2 Graphs.

Record details